Rithm Capital (RITM) Q1 2025 Earnings Transcript

Rithm Capital delivered EAD of $0.52 per diluted share, up 8% year over year, while GAAP net income was $36.5 million and book value stood at $12.39 per share. Management highlighted strong asset gathering, including $3.2 billion of Sculptor real estate commitments, $11.8 billion of Newrez funded originations, and $1.9 billion of quarter-end liquidity, but also emphasized that shares traded at a steep discount to book at $10.40. The company reiterated plans for potential 2025 capital actions, including structural changes, additional funds, and a SPAC vehicle, which should support valuation but are still execution-dependent.

Analysis

RITM’s real story is not quarterly earnings quality; it’s the growing probability of a structural re-rating if management converts “sum-of-parts” rhetoric into a balance-sheet simplification. The market is still pricing this like a levered mortgage REIT, while the business mix is drifting toward fee-driven asset management and asset creation, which should command a materially higher multiple if FRE scales. The key second-order effect is that every incremental dollar moved into off-balance-sheet funds reduces balance-sheet risk while increasing the visibility of recurring fees, making the current discount harder to justify over the next 2-4 quarters.

The most important near-term catalyst is not rate direction but management’s willingness to force a corporate action by year-end. That creates a binary setup: if they announce a C-corp conversion, externalization of Newrez, or a partial IPO/spin of a higher-quality asset-management piece, the stock can rerate quickly; if not, the “unlock value” narrative risks fatigue. The stock also benefits from a rate-volatile tape because the servicing/MSR hedge book should act as an embedded volatility seller, while the company can selectively buy distressed ABF assets when spreads widen.

Competitive dynamics are favorable for RITM but not in the obvious places. The Cooper/Rocket combination likely tightens the competitive field for subservicing and creates a client-acquisition window for Newrez, while the same consolidation should pressure smaller servicers lacking scale and operational tech. That said, the market may be underestimating execution risk: if RITM chases growth too aggressively in originations or M&A, it could dilute the very performance premium management says it needs to earn.

The contrarian view is that the discount is partly self-inflicted and may persist until FRE is large enough to matter. In other words, the market may be right to demand proof that asset management can become a durable earnings engine rather than a call option on fundraising. The best risk/reward comes from owning the equity into a summer/fall catalyst window, not from paying up after a structural announcement is already priced in.

Key Decisions for Investors

• Go long RITM common with a 3-6 month horizon ahead of a year-end capital-action catalyst; target 15-25% upside if management delivers even a partial re-rating, with downside anchored by book value and ongoing dividend support.
• Pair trade: long RITM / short a mortgage-REIT basket (e.g., NLY, AGNC) over the next 1-2 quarters; RITM’s mix shift toward fee income and platform diversification should outperform pure spread-product exposure if volatility stays elevated.
• Buy RITM Jan-2026 call spreads if implied vol remains reasonable; the setup is a catalyst-driven rerating rather than linear earnings growth, so convexity is preferable to outright delta if timing is uncertain.
• Monitor RPT as a higher-beta optionality sleeve for a 6-12 month turnaround, but size small; upside is tied to management proving it can monetize the platform, while downside remains execution-sensitive.
• Do not chase RAC merely as a SPAC story; treat it as a low-conviction option on M&A optionality until there is a specific target and financing structure, because the vehicle’s value is highly path-dependent.